← FDA DRUG APPROVALS

FDA ANDA · ANDA089988

BUTAPAP

Sponsor: MIKART

APPLICATION
ANDA089988
TYPE
ANDA
ORIGINAL APPROVAL
1992-10-26
LATEST ACTION
2002-08-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BUTAPAPDiscontinued
ACETAMINOPHEN 650MG, BUTALBITAL 50MG · TABLET · ORAL

Approval history

2002-08-13Manufacturing (CMC) · Supplement 8AP
2001-03-28Manufacturing (CMC) · Supplement 7AP
2000-07-24Labeling · Supplement 4AP
1998-09-25Manufacturing (CMC) · Supplement 6AP
1998-07-31Manufacturing (CMC) · Supplement 5AP
1995-02-08Manufacturing (CMC) · Supplement 2AP
1994-02-08Labeling · Supplement 1AP
1992-10-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →